EVOKE PHARMA, INC. Share-based Payment Arrangement, Expense
EVOKE PHARMA, INC. reported Share-based Payment Arrangement, Expense of $84.00 thousand for the 6-month period ending 2019-06-30, per its 10-K filed 2021-03-11.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2021-03-11
- EVOKE PHARMA, INC. share-based payment arrangement, expense for the quarter ending 2015-03-31 was $371.60K, a 66.41% increase year-over-year.
- EVOKE PHARMA, INC. share-based payment arrangement, expense for the quarter ending 2014-03-31 was $223.31K.
- EVOKE PHARMA, INC. share-based payment arrangement, expense for fiscal 2014 was $1.10M, a 655.03% increase from fiscal 2013.
- EVOKE PHARMA, INC. share-based payment arrangement, expense for fiscal 2013 was $145.97K.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|
| 2019-06-30 | $84.00K 10-K · filed 2021-03-11 | ||
| 2015-03-31 | $371.60K 10-Q · filed 2015-05-14 | ||
| 2014-12-31 | $1.10M 10-K · filed 2015-03-04 | ||
| 2014-03-31 | $223.31K 10-Q · filed 2015-05-14 | ||
| 2013-12-31 | $145.97K 10-K · filed 2015-03-04 |